{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,4]],"date-time":"2026-10-04T15:19:14Z","timestamp":1791127154887,"version":"4.1.0"},"reference-count":41,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2010,3,20]],"date-time":"2010-03-20T00:00:00Z","timestamp":1269043200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Curr Hematol Malig Rep"],"published-print":{"date-parts":[[2010,4]]},"DOI":"10.1007\/s11899-010-0047-9","type":"journal-article","created":{"date-parts":[[2010,3,19]],"date-time":"2010-03-19T06:52:33Z","timestamp":1268981553000},"page":"62-69","source":"Crossref","is-referenced-by-count":24,"title":["Monoclonal Gammopathy of Undetermined Significance and Smoldering Multiple Myeloma"],"prefix":"10.1007","volume":"5","author":[{"given":"Robert A.","family":"Kyle","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S. Vincent","family":"Rajkumar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2010,3,20]]},"reference":[{"key":"47_CR1","doi-asserted-by":"crossref","first-page":"814","DOI":"10.1016\/0002-9343(78)90522-3","volume":"64","author":"RA Kyle","year":"1978","unstructured":"Kyle RA: Monoclonal gammopathy of undetermined significance. Natural history in 241 cases. Am J Med 1978, 64:814\u2013826.","journal-title":"Am J Med"},{"key":"47_CR2","doi-asserted-by":"crossref","first-page":"1575","DOI":"10.4065\/81.12.1575","volume":"81","author":"JA Katzmann","year":"2006","unstructured":"Katzmann JA, Dispenzieri A, Kyle RA, et al.: Elimination of the need for urine studies in the screening algorithm for monoclonal gammopathies by using serum immunofixation and free light chain assays. Mayo Clin Proc 2006, 81:1575\u20131578.","journal-title":"Mayo Clin Proc"},{"key":"47_CR3","doi-asserted-by":"crossref","unstructured":"\u2022 Katzmann JA, Kyle RA, Benson J, et al.: Screening panels for detection of monoclonal gammopathies. Clin Chem 2009, 55:1517. Serum protein electrophoresis and the serum FLC assay detected 100% of patients with multiple myeloma or WM and 99.5% of those with SMM.","DOI":"10.1373\/clinchem.2009.126664"},{"key":"47_CR4","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1111\/j.0954-6820.1966.tb05453.x","volume":"179","author":"U Axelsson","year":"1966","unstructured":"Axelsson U, Bachmann R, Hallen J: Frequency of pathological proteins (M-components) in 6,995 sera from an adult population. Acta Med Scand 1966, 179:235\u2013247.","journal-title":"Acta Med Scand"},{"key":"47_CR5","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1182\/blood.V40.5.719.719","volume":"40","author":"RA Kyle","year":"1972","unstructured":"Kyle RA, Finkelstein S, Elveback LR, Kurland LT: Incidence of monoclonal proteins in a Minnesota community with a cluster of multiple myeloma. Blood 1972, 40:719\u2013724.","journal-title":"Blood"},{"key":"47_CR6","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1136\/jcp.35.1.63","volume":"35","author":"JP Saleun","year":"1982","unstructured":"Saleun JP, Vicariot M, Deroff P, Morin JF: Monoclonal gammopathies in the adult population of Finistere, France. J Clin Pathol 1982, 35:63\u201368.","journal-title":"J Clin Pathol"},{"key":"47_CR7","doi-asserted-by":"crossref","first-page":"1362","DOI":"10.1056\/NEJMoa054494","volume":"354","author":"RA Kyle","year":"2006","unstructured":"Kyle RA, Therneau TM, Rajkumar SV, et al.: Prevalence of monoclonal gammopathy of undetermined significance. N Engl J Med 2006, 354:1362\u20131369.","journal-title":"N Engl J Med"},{"key":"47_CR8","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/0002-9343(87)90375-5","volume":"82","author":"J Crawford","year":"1987","unstructured":"Crawford J, Eye MK, Cohen HJ: Evaluation of monoclonal gammopathies in the \u201cwell\u201d elderly. Am J Med 1987, 82:39\u201345.","journal-title":"Am J Med"},{"key":"47_CR9","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1016\/S0002-9343(98)00080-1","volume":"104","author":"HJ Cohen","year":"1998","unstructured":"Cohen HJ, Crawford J, Rao MK, et al.: Racial differences in the prevalence of monoclonal gammopathy in a community-based sample of the elderly. [Erratum appears in Am J Med 1998, 105(4):362.] Am J Med 1998, 104:439\u2013444.","journal-title":"Am J Med"},{"key":"47_CR10","doi-asserted-by":"crossref","first-page":"904","DOI":"10.1182\/blood-2005-08-3449","volume":"107","author":"O Landgren","year":"2006","unstructured":"Landgren O, Gridley G, Turesson I, et al.: Risk of monoclonal gammopathy of undetermined significance (MGUS) and subsequent multiple myeloma among African American and white veterans in the United States. Blood 2006, 107:904\u2013906.","journal-title":"Blood"},{"key":"47_CR11","doi-asserted-by":"crossref","first-page":"1468","DOI":"10.1016\/S0025-6196(11)61089-6","volume":"82","author":"O Landgren","year":"2007","unstructured":"Landgren O, Katzmann JA, Hsing AW, et al.: Prevalence of monoclonal gammopathy of undetermined significance among men in Ghana. Mayo Clin Proc 2007, 82:1468\u20131473.","journal-title":"Mayo Clin Proc"},{"key":"47_CR12","doi-asserted-by":"crossref","first-page":"1474","DOI":"10.1016\/S0025-6196(11)61090-2","volume":"82","author":"M Iwanaga","year":"2007","unstructured":"Iwanaga, M, Tagawa M, Tsukasaki K, et al.: Prevalence of monoclonal gammopathy of undetermined significance: study of 52,802 persons in Nagasaki City, Japan. Mayo Clin Proc 2007, 82:1474\u20131479.","journal-title":"Japan. Mayo Clin Proc"},{"key":"47_CR13","doi-asserted-by":"crossref","unstructured":"\u2022 Vachon CM, Kyle RA, Therneau TM, et al.: Increased risk of monoclonal gammopathy in first-degree relatives of patients with multiple myeloma or monoclonal gammopathy of undetermined significance. Blood 2009, 114:785\u2013790. The relative risk of MGUS in relatives of multiple myeloma patients was increased twofold, whereas the risk in relatives of MGUS patients was increased 3.3-fold. This suggests a shared environmental or genetic defect.","DOI":"10.1182\/blood-2008-12-192575"},{"key":"47_CR14","doi-asserted-by":"crossref","unstructured":"\u2022 Iwanaga M, Tagawa M, Tsukasaki K, et al.: Relationship between monoclonal gammopathy of undetermined significance and radiation exposure in Nagasaki atomic bomb survivors. Blood 2009, 113:1639\u20131650. This is the first paper describing the relationship between MGUS and radiation exposure in the Nagasaki atomic bomb explosion. It indicates that only those who were exposed when less than 20\u00a0years of age or those who were within 1.5\u00a0km of the explosion had an increased risk of MGUS.","DOI":"10.1182\/blood-2008-05-159665"},{"key":"47_CR15","doi-asserted-by":"crossref","unstructured":"\u2022 Kyle RA, Rajkumar SV: Epidemiology of the plasma-cell disorders. Best Pract Res Clin Haematol 2007, 20:637\u201364. This is a comprehensive review of the epidemiology of multiple myeloma and related disorders.","DOI":"10.1016\/j.beha.2007.08.001"},{"key":"47_CR16","doi-asserted-by":"crossref","unstructured":"\u2022 Landgren O, Kyle RA, Hoppin JA, et al.: Pesticide exposure and risk of monoclonal gammopathy of undetermined significance in the Agricultural Health Study. Blood 2009, 113:6386\u20136391. Agricultural workers who are exposed to insecticides, herbicides, and fungicides have a 1.9-fold higher risk of MGUS than a normal population.","DOI":"10.1182\/blood-2009-02-203471"},{"key":"47_CR17","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1056\/NEJMoa01133202","volume":"346","author":"RA Kyle","year":"2002","unstructured":"Kyle RA, Therneau TM, Rajkumar SV, et al.: A long-term study of prognosis in monoclonal gammopathy of undetermined significance. N Engl J Med 2002, 346:564\u2013569.","journal-title":"N Engl J Med"},{"key":"47_CR18","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1111\/j.0954-6820.1986.tb03349.x","volume":"219","author":"U Axelsson","year":"1986","unstructured":"Axelsson U: A 20-year follow-up study of 64 subjects with M-components. Acta Med Scand 1986, 219:519\u2013522.","journal-title":"Acta Med Scand"},{"key":"47_CR19","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1111\/j.1365-2141.1992.tb08245.x","volume":"81","author":"J Blade","year":"1992","unstructured":"Blade J, Lopez-Guillermo A, Rozman C, et al.: Malignant transformation and life expectancy in monoclonal gammopathy of undetermined significance. Br J Haematol 1992, 81:391\u2013394.","journal-title":"Br J Haematol"},{"key":"47_CR20","doi-asserted-by":"crossref","first-page":"912","DOI":"10.1182\/blood.V87.3.912.bloodjournal873912","volume":"87","author":"L Baldini","year":"1996","unstructured":"Baldini L, Guffanti A, Cesana BM, et al.: Role of different hematologic variables in defining the risk of malignant transformation in monoclonal gammopathy. Blood 1996, 87:912\u2013918.","journal-title":"Blood"},{"key":"47_CR21","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1046\/j.1365-2141.2001.02533.x","volume":"112","author":"H Gregersen","year":"2001","unstructured":"Gregersen H, Ibsen J, Mellemkjoer L, et al.: Mortality and causes of death in patients with monoclonal gammopathy of undetermined significance. Br J Haematol 2001, 112:353\u2013357.","journal-title":"Br J Haematol"},{"key":"47_CR22","doi-asserted-by":"crossref","unstructured":"Gregersen H, Mellemkjaer L, Salling Ibsen J, et al.: Cancer risk in patients with monoclonal gammopathy of undetermined significance. Am J Hematol 2000, 63:1\u20136.","DOI":"10.1002\/(SICI)1096-8652(200001)63:1<1::AID-AJH1>3.0.CO;2-M"},{"key":"47_CR23","doi-asserted-by":"crossref","unstructured":"Ogmundsd\u00f3ttir HM, Haraldsd\u00f3ttir V, M J\u00f3hannesson G, et al.: Monoclonal gammopathy in Iceland: a population-based registry and follow-up. Br J Haematol 2002, 118:166\u2013173.","DOI":"10.1046\/j.1365-2141.2002.03589.x"},{"key":"47_CR24","first-page":"5640","volume":"58","author":"H Avet-Loiseau","year":"1998","unstructured":"Avet-Loiseau H, Li JY, Facon T, et al.: High incidence of translocations t(11;14)(q13;q32) and t(4;14)(p16;q32) in patients with plasma cell malignancies. Cancer Res 1998, 58:5640\u20135645.","journal-title":"Cancer Res"},{"key":"47_CR25","first-page":"4546","volume":"59","author":"H Avet-Loiseau","year":"1999","unstructured":"Avet-Loiseau H, Facon T, Daviet A, et al.: 14q32 translocations and monosomy 13 observed in monoclonal gammopathy of undetermined significance delineate a multistep process for the oncogenesis of multiple myeloma. Intergroupe Francophone du My\u00e9lome. Cancer Res 1999, 59:4546\u20134550.","journal-title":"Intergroupe Francophone du My\u00e9lome. Cancer Res"},{"key":"47_CR26","doi-asserted-by":"crossref","first-page":"1417","DOI":"10.1182\/blood.V100.4.1417.h81602001417_1417_1424","volume":"100","author":"R Fonseca","year":"2002","unstructured":"Fonseca R, Bailey RJ, Ahmann GJ, et al.: Genomic abnormalities in monoclonal gammopathy of undetermined significance. Blood 2002, 100:1417\u20131424.","journal-title":"Blood"},{"key":"47_CR27","doi-asserted-by":"crossref","first-page":"2156","DOI":"10.1182\/blood-2005-02-0761","volume":"106","author":"WJ Chng","year":"2005","unstructured":"Chng WJ, Van Wier SA, Ahmann GJ, et al.: A validated FISH trisomy index demonstrates the hyperdiploid and nonhyperdiploid dichotomy in MGUS. Blood 2005, 106:2156\u20132161.","journal-title":"Blood"},{"key":"47_CR28","doi-asserted-by":"crossref","unstructured":"\u2022 Anguiano A, Tuchman SA, Acharya C, et al.: Gene expression profiles of tumor biology provide a novel approach to prognosis and may guide the selection of therapeutic targets in multiple myeloma. J Clin Oncol 2009, 27:4197\u20134203. This is an excellent article on gene expression profiling, a technique that will be of greater significance in the future.","DOI":"10.1200\/JCO.2008.19.1916"},{"key":"47_CR29","first-page":"2210","volume":"8","author":"SV Rajkumar","year":"2002","unstructured":"Rajkumar SV, Mesa RA, Fonseca R, et al.: Bone marrow angiogenesis in 400 patients with monoclonal gammopathy of undetermined significance, multiple myeloma, and primary amyloidosis. Clin Cancer Res 2002, 8:2210\u20132216.","journal-title":"Clin Cancer Res"},{"key":"47_CR30","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1359\/jbmr.0301212","volume":"19","author":"LJ Melton 3rd","year":"2004","unstructured":"Melton LJ 3rd, Rajkumar SV, Khosla S, et al.: Fracture risk in monoclonal gammopathy of undetermined significance. J Bone Miner Res 2004, 19:25\u201330.","journal-title":"J Bone Miner Res"},{"key":"47_CR31","doi-asserted-by":"crossref","first-page":"1625","DOI":"10.1200\/JCO.2002.20.6.1625","volume":"20","author":"C Cesana","year":"2002","unstructured":"Cesana C, Klersy C, Barbarano L, et al.: Prognostic factors for malignant transformation in monoclonal gammopathy of undetermined significance and smoldering multiple myeloma. J Clin Oncol 2002, 20:1625\u20131634.","journal-title":"J Clin Oncol"},{"issue":"3","key":"47_CR32","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1182\/blood-2005-03-1038","volume":"106","author":"SV Rajkumar","year":"2005","unstructured":"Rajkumar SV, Kyle RA, Therneau TM, et al.: Serum free light chain ratio is an independent risk factor for progression in monoclonal gammopathy of undetermined significance. Blood 2005, 106:812\u2013817.","journal-title":"Blood"},{"key":"47_CR33","doi-asserted-by":"crossref","unstructured":"\u2022\u2022 Bida JP, Kyle RA, Therneau TM, et al.: Disease associations with monoclonal gammopathy of undetermined significance: a population-based study of 17,398 patients. Mayo Clin Proc 2009, 84:685\u2013693. This is the first report of disease associations in a large number of patients with MGUS. It serves as a guide for determining the importance of clinical entities associated with MGUS.","DOI":"10.4065\/84.8.685"},{"key":"47_CR34","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1111\/j.1365-2141.2006.06235.x","volume":"134","author":"RA Kyle","year":"2006","unstructured":"Kyle RA, Rajkumar SV: Monoclonal gammopathy of undetermined significance. Br J Haematol 2006, 134:573\u2013589.","journal-title":"Br J Haematol"},{"key":"47_CR35","doi-asserted-by":"crossref","unstructured":"\u2022 Landgren O, Kyle RA, Pfeiffer RM, et al.: Monoclonal gammopathy of undetermined significance (MGUS) consistently precedes multiple myeloma: a prospective study. Blood 2009, 113:5412\u20135417. Virtually all patients with multiple myeloma have a preceding MGUS.","DOI":"10.1182\/blood-2008-12-194241"},{"key":"47_CR36","doi-asserted-by":"crossref","first-page":"5418","DOI":"10.1182\/blood-2008-12-195008","volume":"113","author":"BM Weiss","year":"2009","unstructured":"Weiss BM, Abadie J, Verma P, et al.: A monoclonal gammopathy precedes multiple myeloma in most patients. Blood 2009, 113:5418\u20135422.","journal-title":"Blood"},{"key":"47_CR37","doi-asserted-by":"crossref","unstructured":"\u2022\u2022 Kyle RA, Remstein ED, Therneau TM, et al.: Clinical course and prognosis of smoldering (asymptomatic) multiple myeloma. N Engl J Med 2007, 356:2582\u20132590. This is a long-term follow-up of a large series of patients with SMM. The risk of progression was 10% per year for the first 5\u00a0years but fell to 1% to 2% annually after 10\u00a0years of observation.","DOI":"10.1056\/NEJMoa070389"},{"key":"47_CR38","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1046\/j.1365-2141.2003.04654.x","volume":"123","author":"L Rosinol","year":"2003","unstructured":"Rosinol L, Blade J, Esteve J, et al.: Smoldering multiple myeloma: natural history and recognition of an evolving type. Br J Haematol 2003, 123:631\u2013636.","journal-title":"Br J Haematol"},{"key":"47_CR39","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1111\/j.1365-2141.1994.tb04908.x","volume":"87","author":"TE Witzig","year":"1994","unstructured":"Witzig TE, Kyle RA, O\u2019Fallon WM, Greipp PR: Detection of peripheral blood plasma cells as a predictor of disease course in patients with smouldering multiple myeloma. Br J Haematol 1994, 87:266\u2013272.","journal-title":"Br J Haematol"},{"key":"47_CR40","doi-asserted-by":"crossref","first-page":"810","DOI":"10.1046\/j.1365-2141.1997.1122939.x","volume":"97","author":"DM Weber","year":"1997","unstructured":"Weber DM, Dimopoulos MA, Moulopoulos LA, et al.: Prognostic features of asymptomatic multiple myeloma. Br J Haematol 1997, 97:810\u2013814.","journal-title":"Br J Haematol"},{"key":"47_CR41","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1182\/blood-2007-08-108357","volume":"111","author":"A Dispenzieri","year":"2008","unstructured":"Dispenzieri A, Kyle RA, Katzmann JA, et al.: Immunoglobulin free light chain ratio is an independent risk factor for progression of smoldering (asymptomatic) multiple myeloma. Blood 2008, 111:785\u2013789.","journal-title":"Blood"}],"container-title":["Current Hematologic Malignancy Reports"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11899-010-0047-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11899-010-0047-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11899-010-0047-9","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,6,3]],"date-time":"2020-06-03T04:49:14Z","timestamp":1591159754000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11899-010-0047-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,3,20]]},"references-count":41,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2010,4]]}},"alternative-id":["47"],"URL":"https:\/\/doi.org\/10.1007\/s11899-010-0047-9","relation":{},"ISSN":["1558-8211","1558-822X"],"issn-type":[{"value":"1558-8211","type":"print"},{"value":"1558-822X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2010,3,20]]}}}